Drug Manufacturing Innovation Act of 2022
This bill requires the Food and Drug Administration to establish a program to support innovative approaches to pharmaceutical product design and manufacturing, including through grants, regulatory guidance, and working groups.
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2022-03-09 | Committee | Referred to the Subcommittee on Health. | House committee actions |
| 2022-03-08 | IntroReferral | Referred to the House Committee on Energy and Commerce. | House floor actions |
| 2022-03-08 | IntroReferral | Introduced in House | Library of Congress |